학술논문
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, September 2023, 12(18):18643-18653)
Subject
Language
English
ISSN
20457634